Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Q-CTS-hESC-2-RPE
- Development stage
- Unknown
- Lead developer
- Southwest Hospital of Army Medical University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Subretinal
01
Overview
Q-CTS-hESC-2-RPE is a clinical-grade retinal pigment epithelium (RPE) cell therapy derived from the human embryonic stem cell line Q-CTS-hESC-2. It is developed for subretinal transplantation to treat degenerative retinal diseases, including wet age-related macular degeneration (wet AMD) and Stargardt macular degeneration (STGD1). The cells are manufactured under good manufacturing practice (GMP) conditions and have demonstrated biosafety, genetic stability, and functional efficacy in preclinical models as well as early-phase clinical trials. Mechanistically, the therapy aims to replace or support dysfunctional RPE cells in the retina, thereby preserving or improving visual function[1][2][3][4][5]. The product has been shown to be pathogen-free and non-tumorigenic in animal studies[1][2].
- Other names
- Q-CTS-hESC-2-RPEQ-CTS-hESC2-RPEQ-CTS-hESC 2-RPE
Beyond the preview
Go deeper on Q-CTS-hESC-2-RPE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Q-CTS-hESC-2-RPE.